Cytokine ELISA Kits
ELK cytokine ELISA kits
High Purity +100,000 Bioactive Compounds Competitive prices- leader in supply of products for Small molecule screening libraries for cell biology, drug discovery, and drug identification
Genentech's innovative anti-LY6G6D/CD3 bispecific antibody (LY6G6D-TDB) demonstrates potent anti-tumor efficacy in colorectal cancer (CRC) models, both as a standalone treatment and in combination with PD-1 blockade. The most recent research findings have revealed that LY6G6D has emerged as a potential target for the treatment of colorectal cancer. CUSABIO has successfully developed the recombinant antibody specifically targeting human LY6G6D, demonstrating excellent binding activity with both recombinant human LY6G6D protein and recombinant monkey LY6G6D protein.
PCSK9 lipid
ell and gene therapy has never been more exciting with the new advancements and research in this field. However, manufacturing still remains a challenge. Helping our partners navigate and advance their cell and gene therapies has always been our priority. Explore our products at each development step, or learn more about our solutions for Cell and Gene therapy.